Free CME from PeerView


Oncology CME

Credits: 1.0 CME / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Getting to the Heart of Personalized ADT for Advanced Prostate Cancer: Are You Able to Leverage New Data and Therapy Options to Maximize Cardiovascular Safety and Treatment-Related Outcomes?
Daniel J. George, MD
November 15, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
Don’t Miss the Rare When Diagnosing and Treating Autoimmune Hemolytic Anemia: Focus on CAD
Morie A. Gertz, MD
November 09, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Creating a Roadmap for Modern Prostate Cancer Treatment: How to Use the Most Recent Evidence on Novel Therapeutic Strategies and Shared Decision-Making to Personalize Patient Care
Alicia K. Morgans, MD, MPH
October 31, 2022
Credits: 0.75 CME / MOC / NCPD / IPCE
PVI, PeerView Institute for Medical Education
Clinical Conundrums in Pretreated Metastatic Urothelial Carcinoma: Improving Patient Outcomes With Novel Antibody-Drug Conjugates
Scott T. Tagawa, MD, MS, FACP
October 27, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
Harnessing Novel Synergies With Tumor Treating Fields: Insights on Improving Survival With Multimodal Care in Aggressive Tumors
Erik P. Sulman, MD, PhD
October 24, 2022
Credits: 1.0 CME / MOC / NCPD
PVI, PeerView Institute for Medical Education
Breaking Down Barriers to Treatment Adherence and Persistence in HR+/HER2- Early Breast Cancer
Sara M. Tolaney, MD, MPH
October 17, 2022
Credits: 1.0 CME / CC
PVI, PeerView Institute for Medical Education
The Eye-Deal Connection in Multiple Myeloma: Establishing Ophthalmology-Oncology Relationships to Overcome Ocular Toxicity
Praneetha Thulasi, MD / Jonathan L. Kaufman, MD
October 01, 2022
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Precision Decisions in Multimodal Management of Early-Stage NSCLC: Integrating EGFR-Targeted Therapy in Perioperative Settings
Brendon M. Stiles, MD
September 30, 2022
Credits: 0.75 CME / MOC
PVI, PeerView Institute for Medical Education
Extending Survival and Setting Our Sights on Cure in Resectable NSCLC: Getting the Details of Perioperative Immunotherapy Right
Nasser Altorki, MD
September 30, 2022
Credits: 0.5 CME
PVI, PeerView Institute for Medical Education
An "Off-the-Shelf" Approach for Myeloma Care: Visualizing the Present and Future of BCMA Antibodies
Sagar Lonial, MD, FACP
September 30, 2022
Credits: 1.5 CME
PVI, PeerView Institute for Medical Education
SERDs at the Inflection Point in Pretreated ER+/HER2- Breast Cancer: Addressing Unmet Needs, Establishing New Standards of Care, and Improving Patient Outcomes With Novel ER-Targeting Therapies
Javier Cortes, MD, PhD
September 30, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The Power of Personalized Medicine in AML: Linking Individualized Treatment to Enhanced Patient Outcomes
Naval Daver, MD / Amir T. Fathi, MD
September 29, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Challenges and Changes With Targeted Options in CLL: Guidance on Making Evidence-Informed Upfront and Sequential Treatment Choices
Nicole Lamanna, MD / Deborah M. Stephens, DO
September 29, 2022
Sagar Lonial, MD, FACP
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
Progress on the Path to Better Outcomes in RRMM: Expert Perspectives on the Further Integration of BCMA-Directed Antibodies and Cellular Therapies
Sagar Lonial, MD, FACP / Krina Patel, MD, MSc
September 29, 2022
Credits: 1.5 CME / MOC
PVI, PeerView Institute for Medical Education
Targeting HER2-Low Expression in Breast Cancer: Evaluating the Evidence, Challenges, and Opportunities for Expanding Treatment Benefit to More Patients
Professor Aleix Prat, MD, PhD
September 29, 2022
Credits: 1.0 CME / MOC / NCPD / CPE
Medical Learning Institute, Inc.
The “Innovation Moment” Arrives for MDS: Guidance on Building Personalized Management Plans to Improve Patient Outcomes
Guillermo Garcia-Manero, MD / Gail J. Roboz, MD
September 27, 2022
Credits: 0.5 CME / MOC
PVI, PeerView Institute for Medical Education
Optimizing NTRK Fusion Testing and TRK Inhibition in Thyroid Cancer: Team-Based Approaches for Enhanced Outcomes
Marcia S. Brose, MD, PhD, FASCO
September 26, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Refining Biomarker Testing and Targeted Treatment of NSCLC With Common and Uncommon EGFR Mutations
Natasha B. Leighl, MD, MMSc, FRCPC, FASCO
September 25, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and Practical Considerations in Targeting HER2, HER3, TROP2, and Other Alterations in Advanced Lung Cancer
Marina Chiara Garassino, MD
September 25, 2022
Credits: 1.0 CME / MOC
PVI, PeerView Institute for Medical Education
Improving Outcomes in SCLC Through Optimal Integration of the Latest Therapies: Expert Perspectives on the State of the Science, Best Practices, Multidisciplinary Care, and Future Directions
Taofeek K. Owonikoko, MD, PhD
September 24, 2022
Sonia Glennie, ARNP MSN OCN AGPCNP-BC
Credits: 0.5 NCPD / ILNA
PVI, PeerView Institute for Medical Education
Moving Beyond Conventional Care for DLBCL: Oncology Nurse Leadership for the Effective and Safe Use of Innovative Antibody and Cellular Therapies
Sonia Glennie, ARNP, MSN, OCN, AGPCNP-BC
September 14, 2022
Credits: 1.0 CME / MOC / NCPD
Medical Learning Institute, Inc.
Improving Clinical Care With Newer, Better Therapies for Targeting Actionable Gene Fusions in NSCLC
Alexander Drilon, MD
September 02, 2022
Credits: 1.0 CME / MOC / NCPD / CPE / IPCE
PVI, PeerView Institute for Medical Education
Rebooting the BTK Inhibitor Sequence in MCL: Team-Centered Guidance on the Personalized Selection of Covalent and Noncovalent BTK Inhibitors in Relapsed/Refractory Disease
Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD / Nirav Shah, MD, MS
September 02, 2022
Credits: 0.5 CME / MOC / NCPD / IPCE
PVI, PeerView Institute for Medical Education
Harmonizing Interprofessional Care With Modern, Molecularly Informed, and Equitable Therapy for Patients With Advanced Endometrial Cancer: Lessons From a Gynecologic Cancer Center of Excellence
Ritu Salani, MD, MBA
August 30, 2022
Credits: 1.0 CME / MOC / NCPD / ILNA
PVI, PeerView Institute for Medical Education
Uncovering Gene Fusions & Other Key Genomic Alterations in Lung, Thyroid, Colon, Breast, and Other Solid Tumors to Enable All Patients to Gain the Full Benefits of Targeted Treatment
Alexander Drilon, MD
August 16, 2022
Credits: 0.5 NCPD
PVI, PeerView Institute for Medical Education
Reaching the Next Level of Myeloma Patient Care: Oncology Nurse Guidance on Antibody Therapy and Novel Mechanisms of Action
Beth Faiman, PhD, RN, MSN, ANP-BC, AOCN, FAAN
August 11, 2022
Credits: 1.0 CME
Medical Learning Institute, Inc.
Building Real-World Bridges Between Clinicians and Patients With Myeloma: Guidance on Innovative Antibody Options
Robert Z. Orlowski, MD, PhD
July 27, 2022
Credits: 1.0 CME / MOC
Medical Learning Institute, Inc.
The Path for Better Outcomes in ALL: Integrating Modern Asparaginase Compounds Into the Care of Pediatric, AYA, and Adult Patients
Prof. Carmelo Rizzari
July 19, 2022
Credits: 1.0 CME / MOC / NCPD
Penn State College of Medicine
Moving the Treatment of Advanced Gastroesophageal Cancers Forward: How Can We Maximize the Benefits of Novel Immunotherapy Approaches?
Yelena Y. Janjigian, MD
July 15, 2022
Credits: 1.5 CME
Medical Learning Institute, Inc.
New Rules for BTK Inhibitors in CLL: Benchmarks for Evidence-Based Treatment Selection, Sequencing, and Safety Management
Prof. Dr. med. Stephan Stilgenbauer
July 15, 2022

Pages

Upcoming Live Events

Education Collections

Recent CME Podcast

More Podcasts from PeerView